Corcept Therapeutics
CORT
#2837
Rank
โ‚น570.03 B
Marketcap
โ‚น5,310
Share price
-2.22%
Change (1 day)
-16.87%
Change (1 year)

Revenue for Corcept Therapeutics (CORT)

Revenue in 2026 (TTM): โ‚น68.67 Billion

According to Corcept Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น74.09 Billion. In 2025 the company made a revenue of โ‚น68.35 Billion an increase over the revenue in the year 2024 that were of โ‚น57.90 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Corcept Therapeutics from 2009 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น68.67 B0.47%
2025 โ‚น68.35 B18.03%
2024 โ‚น57.90 B44.21%
2023 โ‚น40.15 B20.76%
2022 โ‚น33.25 B22.08%
2021 โ‚น27.24 B5.25%
2020 โ‚น25.88 B18.41%
2019 โ‚น21.85 B24.41%
2018 โ‚น17.56 B72.82%
2017 โ‚น10.16 B83.94%
2016 โ‚น5.52 B65.37%
2015 โ‚น3.34 B98.58%
2014 โ‚น1.68 B163%
2013 โ‚น0.63 B253.38%
2012 โ‚น0.18 B
2011 N/A
2010 N/A-100%
2009 โ‚น1.39 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น9.283 T 12,429.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.450 T 7,256.43%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น6.099 T 8,132.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น6.960 T 9,294.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น6.335 T 8,451.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น4.670 T 6,203.89%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
โ‚น33.61 B-54.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
โ‚น29.26 B-60.50%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น312.34 B 321.57%๐Ÿ‡บ๐Ÿ‡ธ USA